the outbreak started in massachusetts last year. why wasn't the fda responding to these sort of pharmacies? >> well, there was somewhat of a gray area in the law. the fda was responsible for these pharmacies, but there was a court ruling that had put some of their responsibility in to question. since outbreak the fda has been involved more heavily in inspections. but this law is to clarify that and creates a new voluntary category, which is somewhat controversial allowing some of these large pharmacy manufacturing facilities to register themselves and submit themselves to more fda scrutiny similar to the kind a traditional drug manufacturer undergo. >> who are the bill's main sponsors in the senate? >> in the senate it's tom harkin, the head of the health committee, and it is lamar alexander, the republican ranking member of that committee. it's got wide spread support. you don't really have a division between the parties here. in fact, senator alexander, like many other republican senators comes from a state that was badly affected